Literature DB >> 21115625

Cystatin C reduction ratio depends on normalized blood liters processed and fluid removal during hemodialysis.

Shih-Han S Huang1, Guido Filler, Abeer Yasin, Robert M Lindsay.   

Abstract

BACKGROUND AND OBJECTIVES: A negative correlation between the weekly standard Kt/V (urea) and serum cystatin C level (CysC) in functionally anephric dialysis patients has been previously demonstrated. Our objective was to measure the per dialysis CysC reduction ratio (CCRR) and to compare it with other indices of dialytic functions. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In a pilot cross-sectional study of 15 functionally anephric patients on conventional high-flux high-efficiency hemodialysis three times per week, CysC levels were drawn pre-, mid-, and postdialysis over 1 week. CCRR was compared with single-pool Kt/V (Sp Kt/V) using urea kinetic modeling, urea reduction ratio (URR), creatinine reduction ratio (CRR), normalized liters processed (LP/kg), and ultrafiltration volume (UF). Normally distributed data (Shapiro-Wilks test) were described as mean±SD, otherwise as median and interquartile range.
RESULTS: The mean pre- and post-CysC levels were 6.0±1.0 and 4.7±1.1 mg/L. The Sp Kt/V and Std Kt/V were 1.5±0.2 and 2.6. The URR, CRR, and CCRR were 70.2%±9.0%, 64.5%±8.2%, and 26.1%±11.8%, respectively. There was no correlation between the CCRR, and the Sp Kt/V, URR, and CRR, whereas CCRR correlated with LP/kg and UF. Multiple regression analysis with these two parameters provided a model that explained 81% of the variance.
CONCLUSIONS: Our data suggest that normalized liters processed and ultrafiltration volume explain most of the variance of CCRR. Therefore, CCRR may be an excellent method to monitor dialysis efficiency of low molecular weight proteins.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21115625      PMCID: PMC3052222          DOI: 10.2215/CJN.05290610

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  25 in total

1.  Temporal changes of the plasma levels of cystatin C, beta-trace protein, beta2-microglobulin, urate and creatinine during pregnancy indicate continuous alterations in the renal filtration process.

Authors:  K Kristensen; V Lindström; C Schmidt; S Blirup-Jensen; A Grubb; D Wide-Swensson; H Strevens
Journal:  Scand J Clin Lab Invest       Date:  2007       Impact factor: 1.713

2.  Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial.

Authors:  Ramón Paniagua; Dante Amato; Edward Vonesh; Ricardo Correa-Rotter; Alfonso Ramos; John Moran; Salim Mujais
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

3.  Application of cystatin C reduction ratio to high-flux hemodialysis as an alternative indicator of the clearance of middle molecules.

Authors:  Joon-Sung Park; Gheun-Ho Kim; Chong Myung Kang; Chang Hwa Lee
Journal:  Korean J Intern Med       Date:  2010-02-26       Impact factor: 3.165

4.  Body mass does not have a clinically relevant effect on cystatin C eGFR in children.

Authors:  Ajay P Sharma; Anusha Kathiravelu; Renisha Nadarajah; Abeer Yasin; Guido Filler
Journal:  Nephrol Dial Transplant       Date:  2008-09-11       Impact factor: 5.992

5.  Cystatin C levels in functionally anephric patients undergoing dialysis: the effect of different methods and intensities.

Authors:  Najila Al-Malki; Paul A Heidenheim; Guido Filler; Abeer Yasin; Robert M Lindsay
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 8.237

Review 6.  Monitoring renal function and limitations of renal function tests.

Authors:  Alain Prigent
Journal:  Semin Nucl Med       Date:  2008-01       Impact factor: 4.446

7.  Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study.

Authors:  Michael P Delaney; Paul E Stevens; Mohammed Al Hasani; Helen J Stowe; Caroline Judge; Edmund J Lamb
Journal:  Am J Kidney Dis       Date:  2008-02       Impact factor: 8.860

8.  Different elimination patterns of beta-trace protein, beta2-microglobulin and cystatin C in haemodialysis, haemodiafiltration and haemofiltration.

Authors:  Veronica Lindström; Anders Grubb; Maria Alquist Hegbrant; Anders Christensson
Journal:  Scand J Clin Lab Invest       Date:  2008       Impact factor: 1.713

9.  Association between markers of renal function and C-reactive protein level in the elderly: confounding by functional status.

Authors:  E Wasén; R Isoaho; T Vahlberg; S-L Kivelä; K Irjala
Journal:  Scand J Clin Lab Invest       Date:  2008       Impact factor: 1.713

10.  Cystatin C as a risk factor for outcomes in chronic kidney disease.

Authors:  Vandana Menon; Michael G Shlipak; Xuelei Wang; Josef Coresh; Tom Greene; Lesley Stevens; John W Kusek; Gerald J Beck; Allan J Collins; Andrew S Levey; Mark J Sarnak
Journal:  Ann Intern Med       Date:  2007-07-03       Impact factor: 25.391

View more
  9 in total

1.  Residual renal function calculated from serum cystatin C measurements and knowledge of the weekly standard Kt/V urea.

Authors:  Shih-Han S Huang; Guido Filler; Robert M Lindsay
Journal:  Perit Dial Int       Date:  2012 Jan-Feb       Impact factor: 1.756

2.  The Reference Intervals for Serum C-Terminal Agrin Fragment in Healthy Individuals and as a Biomarker for Renal Function in Kidney Transplant Recipients.

Authors:  Dan Yu; Hai-Xia Li; Yi Liu; Ze-Wei Ying; Jing-Jing Guo; Chen-Ying Cao; Jia Wang; Yuan-Fang Li; Hui-Rong Yang
Journal:  J Clin Lab Anal       Date:  2016-09-17       Impact factor: 2.352

Review 3.  Methods of assessing renal function.

Authors:  Guido Filler; Abeer Yasin; Mara Medeiros
Journal:  Pediatr Nephrol       Date:  2013-02-17       Impact factor: 3.714

4.  Removal and rebound kinetics of cystatin C in high-flux hemodialysis and hemodiafiltration.

Authors:  Enric Vilar; Capella Boltiador; Adie Viljoen; Ashwini Machado; Ken Farrington
Journal:  Clin J Am Soc Nephrol       Date:  2014-05-01       Impact factor: 8.237

5.  Levels of cystatin C in low- and high-flux hemodialysis in children with end-stage renal disease.

Authors:  Fatina I Fadel; Abbass A Mourad; Azza M O Abdel Rahman; Hafez M Bazaraa; Mohamed Farouk Mohamed; Dalia H El-Lebedy; Mohamed M Soliman
Journal:  Pediatr Nephrol       Date:  2017-04-17       Impact factor: 3.714

Review 6.  Strategies for the preservation of residual renal function in pediatric dialysis patients.

Authors:  Melissa A Cadnapaphornchai; Isaac Teitelbaum
Journal:  Pediatr Nephrol       Date:  2013-07-19       Impact factor: 3.714

7.  Cystatin C in children on chronic hemodialysis.

Authors:  Olivera Marsenic; Andrea Wierenga; Donna R Wilson; Michael Anderson; Tripti Shrivastava; Garfield A Simon; Anne M Beck; Tiffany J Swanson; Kathleen Studnicka; Dorit Elberg; Kevin Couloures; Martin A Turman
Journal:  Pediatr Nephrol       Date:  2012-11-21       Impact factor: 3.714

Review 8.  Trace elements in dialysis.

Authors:  Guido Filler; Sarah Felder
Journal:  Pediatr Nephrol       Date:  2013-08-16       Impact factor: 3.714

9.  Cystatin C: An alternative dialysis adequacy marker in high flux hemodialysis.

Authors:  K U Maheshwari; S Santhi; R J Malar
Journal:  Indian J Nephrol       Date:  2015 May-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.